StraightArrow__ describes Theranos’s rise to a $9 billion valuation and collapse, including Holmes’s investor-fraud conviction and sentence of more than 11 years in prison.
StraightArrow__ says You Can See Everything, a new documentary directed by Nathan Fielder and Lance Oppenheim, brings renewed attention to Elizabeth Holmes in 2026. Its retrospective traces Holmes’s path from a 19-year-old Stanford dropout to the face of Theranos. The company promised to revolutionize blood testing with just a few drops of blood; investigations, lawsuits and regulatory action followed, along with the criminal trial that ended in her investor-fraud conviction, StraightArrow__ reports.
481
1 post, first seen 3d ago
StraightArrow__ describes Theranos’s rise to a $9 billion valuation and collapse, including Holmes’s investor-fraud conviction and sentence of more than 11 years in prison.
StraightArrow__ says You Can See Everything, a new documentary directed by Nathan Fielder and Lance Oppenheim, brings renewed attention to Elizabeth Holmes in 2026. Its retrospective traces Holmes’s path from a 19-year-old Stanford dropout to the face of Theranos. The company promised to revolutionize blood testing with just a few drops of blood; investigations, lawsuits and regulatory action followed, along with the criminal trial that ended in her investor-fraud conviction, StraightArrow__ reports.
Straight Arrow@StraightArrow__Elizabeth Holmes went from a 19-year-old Stanford dropout to the face of a company valued at $9 billion. Theranos promised to revolutionize blood testing with just a few drops of blood. Then came investigations, lawsuits, regulatory action, and a criminal trial that ended with…
Not enough discussion yet.
No sentiment analysis available yet.
Not enough discussion yet.
No sentiment analysis available yet.
—
Not ranked yet
—
Not ranked yet
Straight Arrow@StraightArrow__Elizabeth Holmes went from a 19-year-old Stanford dropout to the face of a company valued at $9 billion. Theranos promised to revolutionize blood testing with just a few drops of blood. Then came investigations, lawsuits, regulatory action, and a criminal trial that ended with…